Use access key #2 to skip to page content.
$3.44 0.27 (8.52%)
9/5/2008 4:05 PM

Theragenics Corp (TGX)

CAPS Rating:
***

A medical device company serving the cancer treatment and surgical markets. The Company produces, markets and sells TheraSeed(r), its premier palladium-103 prostate cancer treatment device and I-Seed, its iodine-125 based prostate cancer treatment device.

View All Commentary (TGX)

Recs

0

Avatar brownmn (95.92) Submitted: 1/26/08 11:19 PM : Outperform Start Price: $3.47 TGX Score: 5.77

Theragenics is mostly a manufacturer and supplier of brachytherapy technology TheraSeed, used to cure prostate cancer in a minimally invasive way. Demographics indicate there are a lot of old people coming our way, and with them likely cancers.

The company is solid and should grow profits in the coming years. Stock is currently trading near 52 week low.

Report this Post Replies: 0 | Reply

Featured Broker Partners